DR. PADMAJA V MALLIDI M.D.
Prescription History 1629044821
Internal Medicine - Hematology & Oncology in Roanoke, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PADMAJA V MALLIDI M.D., an active Hematology & Oncology specialist practicing in Roanoke, VA. Our medical registry currently tracks 41 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,256 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 129 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| EliquisApixaban | 129 | $853.58 | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 129 Medicare prescriptions for Eliquis, about 1.8 times the volume of the typical Virginia prescriber of this medication (73). Medicare paid an average of $853.58 per fill, versus $843.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 185 30-Day Fills standardized to 30-day supplies 5,548 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 97 | $26.79▼ below VA avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 97 Medicare prescriptions for Anastrozole, about 1.6 times the volume of the typical Virginia prescriber of this medication (61). Medicare paid an average of $26.79 per fill, versus $28.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 237 30-Day Fills standardized to 30-day supplies 7,080 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 67 | $25.89▼ below VA avg | ≈ Typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 67 Medicare prescriptions for Potassium Chloride, about 1.2 times the volume of the typical Virginia prescriber of this medication (56). Medicare paid an average of $25.89 per fill, versus $29.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 95.9 30-Day Fills standardized to 30-day supplies 2,258 Days of Medication total across all patients in 2023 | |||
| Prednisone | 66 | $4.74▼ below VA avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 66 Medicare prescriptions for Prednisone, about 1.4 times the volume of the typical Virginia prescriber of this medication (47). Medicare paid an average of $4.74 per fill, versus $6.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 91.7 30-Day Fills standardized to 30-day supplies 2,408 Days of Medication total across all patients in 2023 | |||
| Letrozole | 61 | $27.69▼ below VA avg | ≈ Typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 61 Medicare prescriptions for Letrozole, about the same volume as the typical Virginia prescriber of this medication (59). Medicare paid an average of $27.69 per fill, versus $37.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 141 30-Day Fills standardized to 30-day supplies 4,186 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 59 | $13.73▼ below VA avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 59 Medicare prescriptions for Levothyroxine Sodium, about half the volume of the typical Virginia prescriber of this medication (121). Medicare paid an average of $13.73 per fill, versus $16.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 125.3 30-Day Fills standardized to 30-day supplies 3,760 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 54 | $42.57 | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 54 Medicare prescriptions for Dexamethasone, about 1.8 times the volume of the typical Virginia prescriber of this medication (30). Medicare paid an average of $42.57 per fill, versus $18.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55.8 30-Day Fills standardized to 30-day supplies 993 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 49 | $1,449.36▼ below VA avg | ▲ More than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 49 Medicare prescriptions for Abiraterone Acetate, about 1.3 times the volume of the typical Virginia prescriber of this medication (37). Medicare paid an average of $1,449.36 per fill, versus $3,036.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 46 | $45.27 | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 46 Medicare prescriptions for Hydroxyurea, about 1.5 times the volume of the typical Virginia prescriber of this medication (30). Medicare paid an average of $45.27 per fill, versus $38.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 108.3 30-Day Fills standardized to 30-day supplies 3,240 Days of Medication total across all patients in 2023 | |||
| Olanzapine | 44 | $32.48▼ below VA avg | ≈ Typical |
About Olanzapine: Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). Show more ▾ It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section. A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. In 2023, this provider wrote 44 Medicare prescriptions for Olanzapine, about the same volume as the typical Virginia prescriber of this medication (44). Medicare paid an average of $32.48 per fill, versus $38.66 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,476 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 43 | $10.34▼ below VA avg | ≈ Typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 43 Medicare prescriptions for Allopurinol, about the same volume as the typical Virginia prescriber of this medication (46). Medicare paid an average of $10.34 per fill, versus $14.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 89.3 30-Day Fills standardized to 30-day supplies 2,680 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 42 | $15.36▼ below VA avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 42 Medicare prescriptions for Acyclovir, about 1.9 times the volume of the typical Virginia prescriber of this medication (22). Medicare paid an average of $15.36 per fill, versus $26.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 70 30-Day Fills standardized to 30-day supplies 1,938 Days of Medication total across all patients in 2023 | |||
| Duloxetine Hcl | 36 | $23.02▼ below VA avg | ≈ Typical |
About Duloxetine Hcl: Duloxetine is used to treat depression and anxiety. Show more ▾ In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2023, this provider wrote 36 Medicare prescriptions for Duloxetine Hcl, about 77% of the volume of the typical Virginia prescriber of this medication (47). Medicare paid an average of $23.02 per fill, versus $43.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2023 | |||
| XtandiEnzalutamide | 26 | $14,723.96 | ≈ Typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 26 Medicare prescriptions for Xtandi, about the same volume as the typical Virginia prescriber of this medication (23). Medicare paid an average of $14,723.96 per fill, versus $13,510.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| Escitalopram Oxalate | 24 | $17.38 | ▼ Less than typical |
About Escitalopram Oxalate: Escitalopram is used to treat depression and anxiety. Show more ▾ It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2023, this provider wrote 24 Medicare prescriptions for Escitalopram Oxalate, about half the volume of the typical Virginia prescriber of this medication (48). Medicare paid an average of $17.38 per fill, versus $16.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 23 | $9.26▼ below VA avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 23 Medicare prescriptions for Alendronate Sodium, about 62% of the volume of the typical Virginia prescriber of this medication (37). Medicare paid an average of $9.26 per fill, versus $11.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 55.4 30-Day Fills standardized to 30-day supplies 1,604 Days of Medication total across all patients in 2023 | |||
| Famotidine | 23 | $16.99 | ≈ Typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2023, this provider wrote 23 Medicare prescriptions for Famotidine, about the same volume as the typical Virginia prescriber of this medication (21). Medicare paid an average of $16.99 per fill, versus $11.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2023 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $27.32 | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 22 Medicare prescriptions for Hydrocodone-Acetaminophen, about a third of the volume of the typical Virginia prescriber of this medication (65). Medicare paid an average of $27.32 per fill, versus $20.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 569 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 21 | $11,759.66▼ below VA avg | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 21 Medicare prescriptions for Calquence, about 1.6 times the volume of the typical Virginia prescriber of this medication (13). Medicare paid an average of $11,759.66 per fill, versus $15,072.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| BrukinsaZanubrutinib | 21 | $14,075.25 | ≈ Typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 21 Medicare prescriptions for Brukinsa, about the same volume as the typical Virginia prescriber of this medication (19). Medicare paid an average of $14,075.25 per fill, versus $13,385.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 20 | $17,940.96 | ≈ Typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 20 Medicare prescriptions for Jakafi, about the same volume as the typical Virginia prescriber of this medication (19). Medicare paid an average of $17,940.96 per fill, versus $16,219.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Oxycodone Hcl | 20 | $21.12▼ below VA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2023, this provider wrote 20 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical Virginia prescriber of this medication (56). Medicare paid an average of $21.12 per fill, versus $25.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 20 30-Day Fills standardized to 30-day supplies 535 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 19 | $9,452.05 | ≈ Typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 19 Medicare prescriptions for Venclexta, about the same volume as the typical Virginia prescriber of this medication (20). Medicare paid an average of $9,452.05 per fill, versus $8,875.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 556 Days of Medication total across all patients in 2023 | |||
| Mirtazapine | 18 | $6.98▼ below VA avg | ▼ Less than typical |
About Mirtazapine: Mirtazapine is used to treat depression. Show more ▾ It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2023, this provider wrote 18 Medicare prescriptions for Mirtazapine, about half the volume of the typical Virginia prescriber of this medication (41). Medicare paid an average of $6.98 per fill, versus $24.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 18 | $22.62▼ below VA avg | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 18 Medicare prescriptions for Tamoxifen Citrate, about half the volume of the typical Virginia prescriber of this medication (32). Medicare paid an average of $22.62 per fill, versus $35.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2023 | |||
| Ondansetron Hcl | 16 | $27.23 | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 16 Medicare prescriptions for Ondansetron Hcl, about 73% of the volume of the typical Virginia prescriber of this medication (22). Medicare paid an average of $27.23 per fill, versus $22.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 300 Days of Medication total across all patients in 2023 | |||
| Folic Acid | 15 | $4.05▼ below VA avg | ▼ Less than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2023, this provider wrote 15 Medicare prescriptions for Folic Acid, about 65% of the volume of the typical Virginia prescriber of this medication (23). Medicare paid an average of $4.05 per fill, versus $5.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| Exemestane | 15 | $98.86▼ below VA avg | ▼ Less than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 15 Medicare prescriptions for Exemestane, about 65% of the volume of the typical Virginia prescriber of this medication (23). Medicare paid an average of $98.86 per fill, versus $250.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 24.4 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $17.15▼ below VA avg | ▼ Less than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2023, this provider wrote 14 Medicare prescriptions for Lidocaine-Prilocaine, about 70% of the volume of the typical Virginia prescriber of this medication (20). Medicare paid an average of $17.15 per fill, versus $25.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 14 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Ondansetron OdtOndansetron | 14 | $33.63 | ▼ Less than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2023, this provider wrote 14 Medicare prescriptions for Ondansetron Odt, about 61% of the volume of the typical Virginia prescriber of this medication (23). Medicare paid an average of $33.63 per fill, versus $24.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 183 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 14 | $15,673.80 | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 14 Medicare prescriptions for Lenalidomide, about 78% of the volume of the typical Virginia prescriber of this medication (18). Medicare paid an average of $15,673.80 per fill, versus $14,126.11 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| AlecensaAlectinib Hcl | 13 | $18,357.54▼ below VA avg | ≈ Typical |
About Alecensa: Alectinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Alectinib belongs to a class of drugs known as tyrosine kinase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Alecensa, about 81% of the volume of the typical Virginia prescriber of this medication (16). Medicare paid an average of $18,357.54 per fill, versus $18,432.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 13 | $18.08 | ▼ Less than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 13 Medicare prescriptions for Prochlorperazine Maleate, about half the volume of the typical Virginia prescriber of this medication (27). Medicare paid an average of $18.08 per fill, versus $17.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 264 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 13 | $3,483.54 | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 13 Medicare prescriptions for Imatinib Mesylate, about 68% of the volume of the typical Virginia prescriber of this medication (19). Medicare paid an average of $3,483.54 per fill, versus $2,345.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| TasignaNilotinib Hcl | 13 | $19,095.92 | ≈ Typical |
About Tasigna: Nilotinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Tasigna, about 76% of the volume of the typical Virginia prescriber of this medication (17). Medicare paid an average of $19,095.92 per fill, versus $15,570.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| PomalystPomalidomide | 12 | $18,552.50▼ below VA avg | ▼ Less than typical |
About Pomalyst: Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 12 Medicare prescriptions for Pomalyst, about half the volume of the typical Virginia prescriber of this medication (28). Medicare paid an average of $18,552.50 per fill, versus $20,760.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $20.81▼ below VA avg | ▼ Less than typical |
About Venlafaxine Hcl Er: Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). Show more ▾ It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. In 2023, this provider wrote 12 Medicare prescriptions for Venlafaxine Hcl Er, about a third of the volume of the typical Virginia prescriber of this medication (31). Medicare paid an average of $20.81 per fill, versus $32.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 20 30-Day Fills standardized to 30-day supplies 579 Days of Medication total across all patients in 2023 | |||
| TagrissoOsimertinib Mesylate | 11 | $18,346.23 | ▼ Less than typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. In 2023, this provider wrote 11 Medicare prescriptions for Tagrisso, about half the volume of the typical Virginia prescriber of this medication (19). Medicare paid an average of $18,346.23 per fill, versus $16,804.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Trazodone Hcl | 11 | $3.26▼ below VA avg | ▼ Less than typical |
About Trazodone Hcl: This medication is used to treat depression. Show more ▾ It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain. In 2023, this provider wrote 11 Medicare prescriptions for Trazodone Hcl, about 18% of the volume of the typical Virginia prescriber of this medication (60). Medicare paid an average of $3.26 per fill, versus $12.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 11 | $14,645.09▼ below VA avg | ▼ Less than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Ibrance, about half the volume of the typical Virginia prescriber of this medication (21). Medicare paid an average of $14,645.09 per fill, versus $15,142.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11 30-Day Fills standardized to 30-day supplies 294 Days of Medication total across all patients in 2023 | |||
| Fentanyl | 11 | $53.95▼ below VA avg | ▼ Less than typical |
About Fentanyl: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use. A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) In 2023, this provider wrote 11 Medicare prescriptions for Fentanyl, about a third of the volume of the typical Virginia prescriber of this medication (29). Medicare paid an average of $53.95 per fill, versus $111.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. PADMAJA V MALLIDI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Roanoke, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among VA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
